Last reviewed · How we verify
NCT04111744
Preoperative Excercise Training for Patients Undergoing Coronary Artery Bypass Graft Surgery
NA trial testing Preoperative Exercise Training in Coronary Artery Disease in 203 participants. Completed in 31 December 2018.
30 June 2018
Quick facts
| Lead sponsor | Kerckhoff Klinik |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 203 |
| Start date | 1 January 2015 |
| Primary completion | 30 June 2018 |
| Estimated completion | 31 December 2018 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Preoperative Exercise Training
- Optimal medical therapy — full drug profile →
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
- Physical Activity — all drugs for Physical Activity →
- Coronary Artery Bypass Graft Surgery — all drugs for Coronary Artery Bypass Graft Surgery →
Sponsor
Kerckhoff Klinik
Who can join
50 and older, any sex, with Coronary Artery Disease or Physical Activity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients (pts) with stable coronary artery disease (CAD) requiring coronary artery bypass graft surgery (CABG) may be physically inactive during the waiting period to avoid further risks. Aim of this study is to investigate the feasibility and safety of a preoperative aerobic exercise training in these pts during the waiting period and to analyze its effects on pre-, peri and postoperative outcomes
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prehabilitation in patients awaiting elective coronary artery bypass graft surgery - effects on functional capacity and quality of life: a randomized controlled trial.
Steinmetz C, Bjarnason-Wehrens B, Baumgarten H, Walther T, et al · · 2020 · cited 54× · PMID 32546065 · DOI 10.1177/0269215520933950
Verify or expand the search:
- PubMed search for NCT04111744
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Kerckhoff Klinik trials
Trials by the same sponsor.
- NCT07299227 — Impact of BPA in CTEPH on Cardiac and Pulmonary Physiology Assessed by CMR-derived 4D Flow Haemodynamics · recruiting
- NCT07018778 — CMR-derived Quantitative Perfusion for Prediction of FFR · not yet recruiting
- NCT03023475 — Comparison of Two Different Endoscopic Radial Artery Harvesting Devices · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04111744 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kerckhoff Klinik
- Last refreshed: 1 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04111744.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing